Product Information
TESTOSTERONE 12.5 MG/1.25 GRAM is a generic product labeled by Actavis Pharma, Inc., priced at $0.8264 per GM under NDC 00591292102. Its NADAC has been published 486 times since Jun 14, 2017.
FDA first approved this application on Jan 27, 2006. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10 mg/g
Manufacturer
Actavis Pharma, Inc.NDC
00591292102
Classification
Generic
Dosage Form
GEL
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
TESTOSTERONEApproval Type
Generic (ANDA)
FDA Application
ANDA076737FDA Approved
1/27/2006
TE Code
AB1
On Market Since
12/14/2015
Pharmacological Classes
Price Statistics
The NADAC for TESTOSTERONE 12.5 MG/1.25 GRAM has been published 486 times since Jun 14, 2017, and over the history we have for it it has declined 54.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.8264 per GM |
|---|---|
| All-time high | $1.7964 (Jun 14, 2017) |
| All-time low | $0.6126 (Jul 22, 2026) |
| 52-week high | $1.0033 |
| 52-week low | $0.6126 |
| Median price | $1.0988 |
| Average price | $1.0897 |
| Largest weekly change | +47.2% (Aug 21, 2024) |
| Weeks tracked | 486 |
| Tracking since | Jun 14, 2017 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 51% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Actavis Pharma, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Testosterone market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Androgen class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TESTOSTERONE 12.5 MG/1.25 GRAM?
The current National Average Drug Acquisition Cost (NADAC) for TESTOSTERONE 12.5 MG/1.25 GRAM, manufactured by Actavis Pharma, Inc., is $0.8264 per GM (NDC 00591292102), effective Sep 30, 2026.
How has the price of TESTOSTERONE 12.5 MG/1.25 GRAM changed over time?
Over the history we have for it, the NADAC for TESTOSTERONE 12.5 MG/1.25 GRAM has declined 54.0%. It has been tracked across 486 weekly CMS publications since Jun 14, 2017.
What are the highest and lowest recorded NADAC prices for TESTOSTERONE 12.5 MG/1.25 GRAM?
Since Jun 14, 2017, the NADAC for TESTOSTERONE 12.5 MG/1.25 GRAM has ranged from a low of $0.6126 (Jul 22, 2026) to a high of $1.7964 (Jun 14, 2017), with a median of $1.0988 per GM.
Are there cheaper alternatives to TESTOSTERONE 12.5 MG/1.25 GRAM?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TESTOSTERONE 1% (50 MG/5 G) PK, is $0.4061 per GM — about 51% below TESTOSTERONE 12.5 MG/1.25 GRAM.
Who manufactures TESTOSTERONE 12.5 MG/1.25 GRAM?
TESTOSTERONE 12.5 MG/1.25 GRAM (NDC 00591292102) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.